Cancer & Blood Disease Center

Lecanto, Florida 34461

0 studies enrolling now · 8 studies all time

What they study most

Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic, Multiple Myeloma, Myelodysplastic Syndrome, Myelodysplastic Syndromes, NSCLC, Refractory Multiple Myeloma, Relapsed Multiple Myeloma

Studies at this site

• Connect® MM- The Multiple Myeloma Disease Registry — Stopped early
• A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma — Completed
• A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. — Stopped early
• Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003 — Completed
• Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality — Completed
• A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia — Completed
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone — Completed
• Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes — Completed